首页 > 最新文献

Current Controlled Trials in Cardiovascular Medicine最新文献

英文 中文
Diabetes and insulin use on AMI survival - is enough being done? 糖尿病和胰岛素对急性心肌梗死生存的影响——是否足够?
Pub Date : 2001-10-18 DOI: 10.1186/CVM-2001-72101
J. Lyford
{"title":"Diabetes and insulin use on AMI survival - is enough being done?","authors":"J. Lyford","doi":"10.1186/CVM-2001-72101","DOIUrl":"https://doi.org/10.1186/CVM-2001-72101","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"689 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2001-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76880143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statins not effective in reducing osteoporotic fractures 他汀类药物对减少骨质疏松性骨折无效
Pub Date : 2001-10-18 DOI: 10.1186/CVM-2001-72053
J. Lyford
{"title":"Statins not effective in reducing osteoporotic fractures","authors":"J. Lyford","doi":"10.1186/CVM-2001-72053","DOIUrl":"https://doi.org/10.1186/CVM-2001-72053","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"15 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2001-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84006650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary event risk needs to be quantified before advising aspirin for primary prevention 在建议使用阿司匹林进行一级预防之前,需要对冠状动脉事件风险进行量化
Pub Date : 2001-10-18 DOI: 10.1186/CVM-2001-72100
J. Lyford
{"title":"Coronary event risk needs to be quantified before advising aspirin for primary prevention","authors":"J. Lyford","doi":"10.1186/CVM-2001-72100","DOIUrl":"https://doi.org/10.1186/CVM-2001-72100","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"15 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2001-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84333397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary changes take two years to reduce heart attack risk 改变饮食习惯需要两年时间才能降低心脏病发作的风险
Pub Date : 2001-10-17 DOI: 10.1186/CVM-2001-71954
J. Lyford
{"title":"Dietary changes take two years to reduce heart attack risk","authors":"J. Lyford","doi":"10.1186/CVM-2001-71954","DOIUrl":"https://doi.org/10.1186/CVM-2001-71954","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"18 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2001-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86818278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytokines as new treatment targets in chronic heart failure 细胞因子作为慢性心力衰竭的新治疗靶点
Pub Date : 2001-10-16 DOI: 10.1186/cvm-2-6-271
J. Damås, L. Gullestad, P. Aukrust
{"title":"Cytokines as new treatment targets in chronic heart failure","authors":"J. Damås, L. Gullestad, P. Aukrust","doi":"10.1186/cvm-2-6-271","DOIUrl":"https://doi.org/10.1186/cvm-2-6-271","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"11 1","pages":"271 - 277"},"PeriodicalIF":0.0,"publicationDate":"2001-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78973036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 46
Withdrawal of cerivastatin from the world market cervastatin从世界市场撤回
Pub Date : 2001-09-26 DOI: 10.1186/cvm-2-5-205
C. Furberg, B. Pitt
{"title":"Withdrawal of cerivastatin from the world market","authors":"C. Furberg, B. Pitt","doi":"10.1186/cvm-2-5-205","DOIUrl":"https://doi.org/10.1186/cvm-2-5-205","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"2 1","pages":"205 - 207"},"PeriodicalIF":0.0,"publicationDate":"2001-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88278079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 365
Diuretics: again the first step in the treatment of most patients with hypertension 利尿剂:再次是大多数高血压患者治疗的第一步
Pub Date : 2001-09-25 DOI: 10.1186/cvm-2-5-244
F. Fuchs
{"title":"Diuretics: again the first step in the treatment of most patients with hypertension","authors":"F. Fuchs","doi":"10.1186/cvm-2-5-244","DOIUrl":"https://doi.org/10.1186/cvm-2-5-244","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"41 1","pages":"244 - 248"},"PeriodicalIF":0.0,"publicationDate":"2001-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87349275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Anti-atherogenic effects of fibrates in type 2 diabetes 贝特类药物对2型糖尿病的抗动脉粥样硬化作用
Pub Date : 2001-09-24 DOI: 10.1186/cvm-2-5-218
P. Barter
{"title":"Anti-atherogenic effects of fibrates in type 2 diabetes","authors":"P. Barter","doi":"10.1186/cvm-2-5-218","DOIUrl":"https://doi.org/10.1186/cvm-2-5-218","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"16 1","pages":"218 - 220"},"PeriodicalIF":0.0,"publicationDate":"2001-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87367392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins 解释ALLHAT和V-HeFT试验不良结果的假设:热休克蛋白表达减少
Pub Date : 2001-09-20 DOI: 10.1186/cvm-2-6-251
P. Hooper
{"title":"Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins","authors":"P. Hooper","doi":"10.1186/cvm-2-6-251","DOIUrl":"https://doi.org/10.1186/cvm-2-6-251","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"16 1","pages":"251 - 253"},"PeriodicalIF":0.0,"publicationDate":"2001-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87397035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
ELITE II and Val-HeFT are different trials: together what do they tell us? ELITE II和Val-HeFT是不同的试验:它们一起告诉我们什么?
Pub Date : 2001-09-19 DOI: 10.1186/cvm-2-5-240
K. Dickstein
{"title":"ELITE II and Val-HeFT are different trials: together what do they tell us?","authors":"K. Dickstein","doi":"10.1186/cvm-2-5-240","DOIUrl":"https://doi.org/10.1186/cvm-2-5-240","url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"29 1","pages":"240 - 243"},"PeriodicalIF":0.0,"publicationDate":"2001-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80509812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
期刊
Current Controlled Trials in Cardiovascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1